Epivios

Recent Finacing

Equity

Recent Raise

Undisclosed

Epivios develops epigenetics-based molecular diagnostic assays for cancer, using a platform that standardizes comparisons across differing genetic backgrounds and analyzes genome-spanning methylation sequences for clinical validation and lab deployment.